SNOMED CT Editorial Guide

Search

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

Version 1 Next »

Overview

Pharmaceutical dose form grouper concepts based on intended site of use for the dose form that are deemed to be clinically useful or which provide a helpful organizing grouper and that can be sufficiently defined may be included in the 736542009 |Pharmaceutical dose form (dose form)| hierarchy.

These concepts are used in modeling (medicinal product form) concepts in the International Release; they are not allowed to model (clinical drug) concepts in the International Release.

Modeling (stated view)

Pharmaceutical dose form grouper concepts based on intended site shall be modeled using the proximal primitive modeling pattern. 

Parent concept

736542009 |Pharmaceutical dose form (dose form)

Semantic tag

(dose form)

Definition status

900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|

Attribute:

Has dose form intended site

  • Range: << 736479009 |Dose form intended site (intended site)
  • Cardinality: 0..*
    • NOTE: While the allowed range is broader, the grouper concepts based on dose form intended site should have one or more |Has dose form intended site| attributes.

Naming Guidelines

FSN

Use the following pattern for the FSN; align naming and case sensitivity with the FSN for the concept that is selected as the attribute value, excluding the semantic tag. For multiple intended sites, the intended sites must be in alphabetical order and separated by the word “or”.

  • <Dose form intended site FSN> dose form (dose form)
  • <Dose form intended site FSN> or <Dose form intended site FSN> dose form (dose form)

Example:

  • Cutaneous dose form (dose form)
  • Oral dose form (dose form)
  • Parenteral dose form (dose form)
  • Ocular or otic dose form (dose form)
  • Nasal or ocular or otic dose form (dose form)

Preferred Term

Use the following pattern for the PT; align naming and case sensitivity with the PT for the concept that is selected as the attribute value. For multiple intended sites, the intended sites must be in alphabetical order and separated by the word “or”.

  • <Dose form intended site PT> dose form (dose form)
  • <Dose form intended site PT> or <Dose form intended site PT> dose form (dose form)

Example:

  • Cutaneous dose form
  • Oral dose form
  • Parenteral dose form
  • Ocular or otic dose form
  • Nasal or ocular or otic dose form

Synonyms

Synonyms are not allowed unless explicitly identified as an exception in the Editorial Guidelines.

Text definitionsOptional

Exemplars

The following illustrates the stated view for grouper concept 740596000 |Cutaneous dose form (dose form)|:

The following illustrates the inferred view for grouper concept 740596000 |Cutaneous dose form (dose form)|:

The following illustrates the stated view for grouper concept 765166009 |Ocular or otic dose form (dose form)|:

The following illustrates the inferred view for grouper concept 765166009 |Ocular or otic dose form (dose form)|:



Feedback
  • No labels